Clinical trial
Prospective Study of Glucocorticoids as a Mechanism to Treat Pulmonary Hypertension
NCT04499196 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study of Glucocorticoids as a Mechanism to Treat Pulmonary Hypertension
- Lead sponsor
- Washington University School of Medicine
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 29, 2020
- Completion date
- July 29, 2022
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bronchopulmonary dysplasia, pulmonary hypertension, pulmonary hypertension due to lung diseases and hypoxia